Covid-19 Vaccine: Cure or Curse?

A gold mine of information – updated 25 June 2021

CONTENT on this page below: (red  = updated)
Intro Summary • Videos UK adverse Reactions Questioning The Vaccine Rollout • Pfizer Covid Vaccine • AstraZeneca Vaccine  Pfizer EU Tazinameran & Israel • Better 12 Weeks Apart  Prion Disease • Nanoparticles • FDA Concerns • Trial Questions • Immune Enhancement • Trials Rigged? • Ecological Damages • Law Violations • Virus Mutations  Vaccine Development • Early Warnings • Is This the end?  HealthTruth Comment ARCHIVE covid vaccine data UK

Intro Summary: updatd 15 June 2021

Is the Covid-19 vaccine safe? It is a new mRNA gene therapy technology. Below you find data from the UK government – and a different way how to interpret them and put them into context.
mRNA vaccines have never been licensed before. RNA is the only molecule known to recapitulate all biochemical functions of life: definition, control, and transmission of genetic information

Since the Severe Acute Respiratory Syndrome (SARS-1) outbreak in 2002 there have been numerous coronavirus vaccine animal studies conducted: either the animals were not completely protected, became severely ill with accelerated autoimmune conditions, or died, primarily attributed to what is called Antibody-Dependent Enhancement (ADE).
The SARS-CoV-2 virus (which can cause covid-19 symptoms) is from the same cronavirus family as SARS-1.
Experimental vaccines for SARS, MERS, HIV, and other diseases have not been proven effective and safe for humans.

Pfizer’s and Moderna’s mRNA vaccines are coated with PEGylated lipid nanoparticles (polyethylene glycol). This coating hides the mRNA from our immune system which ordinarily would attack and destroy kill any foreign material. PEGylated lipid nanoparticles have been shown to imbalance certain immune responses and can induce allergies and even autoimmune diseases.
Neither Pfizer/BioNTech nor Moderna have ‘completely’ disclosed everything in their vaccines. [source]

The following comparison clearly shows: covid-19 is not a normal vaccine in terms of reported side effects. The diagramme for 2021 is based on less than half a year of reporting:

Figure 1: “side effects of important vaccines from the year 2000 in the WHO database VigiAccess”. Source:

Normally a vaccines would need to be tested AT LEAST five years.
Fast-track policy is a recipe for mass disaster.
Vaccine manufacturers unlimited freedom to create, develop, and market vaccines without any liability.

All covid-19 vaccines are 'Leaky' vaccines, only preventingsymptoms, NOT infection or virus transmission

WARNING: As the vaccines are gradually offered to younger people, we can expect MORE adverse reactions:Adverse reactions were generally milder and reported less frequently in older adults (65 years and older) than in younger people.” [quote from UK government Coronavirus vaccine – weekly summary of Yellow Card report]

Some UK adverse reactions to covid-19 vaccines compared to the six covid-19 symptoms
Six screenshots from the UK Yellow Card Analysis of the AstraZeneca vaccine,
listing adverse effect on now 116 pages.

Covid-vaccines are not just “normal” vaccines like the ones we have for decades: About 200 flu vaccine fatalities were counted in 54 years ( = 4 / year)
Unreported by the media, the 1000th covid vaccine fatality was registered on the UK Yellow Card scheme around 18th of April 2021.

According to the UK Yellow Card scheme,
Flu vaccines caused about 4 deaths / year
= 1 death in 3 months.
mRNA Pfizer = 236 deaths in 3 months
AstraZeneca = 521 deaths in 3 months

When it comes to adverse events, covid vaccines are off the scale of traditional vaccines:

Comparing UK Yellow Card adverse events of HPV,  MMR & influenza virus vaccine data until 8 June 2017
with covid vaccine adverse events until 5 april 2021
Sources: the HPV, MMR & influenza virus vaccine data until 8 June 2017 were sent from MHRA by email on request.
AstraZeneca Yellow Card data, Pfizer Yellow Card data – both updated Thurdays
VAERS data show more than 10 times as many covid vaccine fatalities than the usual vaccines. VAERS is the US equivalent to the UK’s Yellow Card scheme.

Up to TOP Table of Content

Videos Covid Vaccine Safety updated 18 March

If you prefer watching 20 experts each giving their view on the coronavirus vaccines in less than one hour: below is a video, covering many of the vaccine aspects:

ASK THE EXPERTS II | Oracle Films | CoviLeaks | 2021 BBC Panorama Response - Share the video link:

For many decades Dr. Vernon Coleman has been a “canary in the coal mine” giving early warnings about things which would possibly go wrong (like asbestos not being healthy to use). He always seems to be ahead of the game. Please do listen to his warning what the covid vaccines might do to our immune system with possibly fatal outcome – STRONG warning to humanity.
You can link to to share his video. [social media may restrict posts to brandnewtube links]

Up to TOP Table of Content

UK Adverse Reactions to Covid-Vaccines updated 26 June 2021

With 11 days delay, the UK government publishes the cumulative total numbers of adverse reactions and fatalities after the covid vaccine was administered.

UK government website for data and insights on coronavirus (COVID-19) (positive tests, deaths within 28 days, hospital admissions, virus tests. Updated daily)
Weekly UK Yellow Card reports of adverse covid vaccine reactions
(updated Thursdays), with the detailed analysis prints and cumulative total data.

Cumulative UK Yellow Card adverse reactions, updated Thursdays
Oxford University/AstraZeneca analysis print (116 pages!)
mRNA PfizerBioNTech analysis print (88 pages)
COVID-19 vaccine brand unspecified analysis print (28 pages)
NEW: Vaccine Analysis Print – Moderna (41 pages)

Yellow Card Covid vaccine adverse reactions UK by 16 June 2021
Data collected from the weekly published UK data and weekly Oxford University/AstraZeneca analysis print and mRNA PfizerBioNTech analysis print
Additionally the 16 June “unspecified brand” shows 22 fatalities +”Moderna” 5

By 16th of June 2021, a total of
1356 fatalities were reported as covid vaccine adverse reactions
in UK Yellow Cards Data Analysis Prints.
AstraZeneca’s DAP reports are now
116 pages long.

Quietly and ignored by the main stream media we reached 1000 UK deaths reported after receiving a covid vaccine in April.
Additionally there are 13 deaths listed under “unspecified brand”
and 2 brand new casualties after the 1st 100 000 were vaccinated with the Moderna vaccine:

Statistics and data are a minefield..
The data are collected and processed in the 10 days after each week ending Sunday, and published Thursdays 11 days later; if someone reports a death or reaction on day 12 or later, it is not included, but will (hopefully) be added to the totals published the following week.
The Yellow Card analysis prints do not indicate, wether reactions and fatalities occurred after the 1st or after the 2nd shot.
THIS makes it difficult to analyse the data.

A 2010 study of the US VAERS scheme concludes:”Adverse events from drugs and vaccines are common, but underreported. Although 25% of ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration (FDA).
Likewise, fewer than 1% of vaccine adverse events are reported … New surveillance methods for drug and vaccine adverse effects are needed.
Barriers to reporting include a lack of clinician awareness, uncertainty about when and what to report, as well as the burdens of reporting: reporting is not part of clinicians’ usual workflow, takes time, and is
VAERS is similar to the UK Yellow Card scheme, and not much has changed in the last 11 years.
The real post-vaccine reactions and fatalities might be 100x higher than the reported numbers below as only 1% of adverse reactions gets submitted.

Comparison covid-19 vaccine adverse reactions with fatal outcome in the UK Yellow Card “Case Series Drug Analysis Print” Data Lock Date: 21-Mar-2021
Data from the UK Yellow Card Analysis of AstraZeneca and Pfizer vaccine

The UK MHRA reports on 1 April:
In the week since the previous summary for 14 March 2021 we have received a further 2,799 Yellow Cards for the Pfizer/BioNTech vaccine, 24,594 for the Oxford University/AstraZeneca vaccine and 54 where the brand was not specified. A higher number of doses of the Oxford University/AstraZeneca vaccine were administered in the last week than the Pfizer/BioNTech vaccine.”
These late reports indicate
1) AstraZeneca contributes MUCH more than Pfizer
2) That’s a concerning amount of adverse effects after day 11

The deaths registered above are just the tip of the iceberg:
The report rate in the UK population is less than 1%:

Comparing side effects of Pfizer and AstraZeneca covid vaccine trials with UK Yellow Card reports of adverse reactions 28 February 2021
The comparison of side effects recorded in the vaccine trials
with those reported in the UK YellowCard Scheme by 28 February 2021 reveal:
1) AstraZeneca shows a multitude more side effects than the Pfizer vaccine
2) Far less than 1% of post vaccine side effects are reported in the Yellow Card scheme

Compare the %age of Yellow Card reports with the documented %age of adverse reactions in the trials above!
Keep in mind, that the trials used healthy volunteers.

1st covid-19 vaccine doses administered by 21 March:
15.8 million doses Oxford University/AstraZeneca
10.8 million first doses of the Pfizer/BioNTech
2.2 million second doses, mostly the Pfizer/BioNTec.
Total reports UK Yellow Card up to 21 March 2021:

377 487 Reactions
99 817 Reports
421 Fatal [from which
184 unidentified cause]

Pfizer vaccine:
116 627 Reactions
40 883 Reports
283 Fatal [from which
121 unidentified cause]

1231 reactions
379 Reports
9 Fatal [from which
4 unidentified cause]

1st and 2nd dose of covid vaccine given in the UK by 5 April 2021 shows a recent decrease. Source:

Screenshot of the updated UK Coronavirus Dashboard showing the R number, positive test “cases”, deaths, hospitalisations and SARS-CoV-2 tests:

the screenshot from on 4 April 2021 shows:
R number is below 1, “cases”, deaths and hospital admissions are past their peak.

That is 40x more deaths than expected after a flu vaccine!
WHO statement from 2013:
for every 10 million individuals vaccinated [against Influenza A (H1N1)] in the UK, 21.5 cases of Guillain-Barré syndrome and 5.75 sudden deaths were expected to occur as unrelated coincidental events within 6 weeks of vaccination. 34” [VACCINE SAFETY BASICS, p 77]

Earlier UK Data see ARCHIVE @ End

In the last decades, less than 10% of vaccine reactions and fatalities have been reported with the Yellow Card scheme – nearly always they are considered “coincidental”, but not causal [BMJ].
A study found, that in the US “Vaccine Adverse Event Reporting System” VAERS “fewer than 1% of vaccine adverse events are reported
The real vaccine adverse effects and deaths will be at least 20 times higher.
Vaccine authorities don’t really want to know about adverse effects.
QUESTION: are UK vaccine deaths after day 8 included?

Data compiled from

Vaccine Deaths In The News:

13 Feb 2021: 12 Residents Die After First COVID Vaccine at Fairways Newydd Nursing and Dementia Care Centre in Anglesey, Wales while 36 residents and 54 staff are now testing positive for COVID after an outbreak of covid-19, the North Wales Chronicle reports. Is this just a coincidence?

28 Jan 2021:
22 Deaths at Pemberley House:
22 people have died (over 1/3 of the residents!) at Pemberley House in Basingstoke / UK after receiving the covid-19 vaccine.
The Medicines and Healthcare Products Regulation Agency (MHRA) said there was no suggestion the vaccine was responsible for the deaths.

22 people have asdied (over 1/3 of the residents!) at Pemberley House in Basingstoke / UK after receiving the covid-19 vaccine.
1/3 of the residents died within three weeks after the covid-19 vaccination at Pemberley House: Residential, Nursing, Dementia & Respite Care [Daily Echo]

A spokesperson for the MHRA said “our surveillance does not suggest that the COVID-19 vaccines have contributed to any deaths... It is not unexpected that some of these people may naturally fall ill due to their age or underlying conditions shortly after being vaccinated, without the vaccine playing any role in that.”
Cllr James said “The important thing now is to ensure that nothing stops the rollout of the vaccine...I think the vaccine programme seems to be working very well. It is some good news at last.” [Daily Echo 28 Jan 2021]

Up to TOP Table of Content

Questioning The “Vaccine” Rollout updated 21 Dec 2020

NEWS: since 1st of April 2021, a third covid vaccine, “Moderna” is approved to be used in the UK

after the first of two doses of the Moderna COVID-19 vaccine, 80% of Phase 1 participants receiving the 100 microgram (mcg) dose developed systemic side effects.21
After the second dose, 100% reported side effects ranging from fatigue (80%), chills (80%), headache (60%) and myalgia or muscle pain (53%).
“One of the participants in Pfizer’s vaccine trial “woke up with chills, shaking so hard he cracked a tooth after taking the second dose.” [source]

21 December: The CDC reports that having received the m-RNA COVID-19 vaccine 2.8% had a “Health Impact Event” =
“**unable to perform normal daily activities, unable to work, required care from doctor or health care professional
The daily % increase of Health Impact Events in the table below is concerning0.44%, 0.82%, 1.34%, 2.17%, 2.79%…

CDC study shows: percentage of Health Impact Events increases in the 1st 4 days of Pfizer covid-19 vaccine from 0.4% to 2.8%
Screen shot from

What technology do leading SARS-CoV-2 vaccines use?
Viral vector vaccines: Johnson & Johnson,
Oxford-AstraZeneca, Gamaleya Research Institute
mRNA vaccines: Pfizer-BioNTech, Moderna
Inactivated vaccines:
Sinopharm, Sinovac, Sinopharm-Wuhan, Bharat Biotech
Protein based vaccines: Novavax
[source: BMJ 1 Feb 2021]

If you prefer listening to a clear scientific easy to understand podcast, listen to Wise Traditions 292: It’s Gene Therapy, Not a Vaccine with Dr. David Martin (also professor, author and inventor) [25 Jan 2021]
And here is the transcript: “It’s Gene Therapy, Not a Vaccine

This is not a vaccine. This is gene therapyIt’s a chemotherapy agent that is gene therapy… What is this doing? It’s sending a strand of synthetic RNA into the human being and is invoking within the human being, the creation of the S1 spike protein, which is a pathogen.
It’s a toxin inside of human beings. This is not only not keeping you from getting sick, it’s making your body produce the thing that makes you sick.” [Dr. David Martin]

Here is an overview of a science article discussing covid vaccines:

best critical analysis“: “COVID-19 mRNA Vaccines
by James Odell, OMD, ND, L.Ac, Dec 28, 2020
including the following chapters:
History of Coronavirus Vaccine Animal Studies and Antibody Dependent Enhancement (ADE)
Technical Understanding of SARS-CoV-2 ADE Mechanisms
Traditional vs. mRNA Vaccines and Mechanisms
PEGylated Lipid Nanoparticles.
Production of mRNA vaccines
Current mRNA Vaccines and Potential Side-Effects
Moderna and Pfizer Vaccine Ingredients and Dosage
mRNA Vaccine Viral Shedding and Vaccine Interference
SARS-CoV-2 Spike Protein Shares Sequence with a Human Protein Syncytin-1
Adjuvants. Stability and Storage. Deployment.
No Liability Due to the PREP Act. Conclusion

Quotes from the official UK Government “Information for UK recipients on Pfizer/BioNTech COVID-19 vaccine“:
COVID-19 mRNA Vaccine BNT162b2 concentrate for solution for injection. Read all of this leaflet carefully before you receive this vaccine because it contains important information for you.

As the above quoted patient information leaflet is a bit vague,
below are quotes from the detailed UK healthcare professionals.

Check the statistical details in the two REG 174 UK government infos below, Pfizer and AstraZeneca vaccines, 5.1 efficacy.
The “case definition” of what the vaccine aims to prevent does NOT include serious adverse effects of covid-19.
Efficacy measures the performance of a treatment under ideal and controlled circumstances, while
Effectiveness is the performance under real-world conditions.

Up to TOP Table of Content

Pfizer COVID-19 mRNA “Vaccine” BNT162b Info updated 26 Jan 2021

All quotes in the white box below about the Pfizer vaccine are from the UK government website, selected and important passages marked in bold by

Quotes from REG 174 Information for UK Healthcare professionals for COVID-19 mRNA Vaccine BNT162b2 [from Pfizer]
[bold/colour highlights added by]
2. COVID-19 mRNA Vaccine BNT162b2 is highly purified single-stranded, 5’-capped messenger RNA
(mRNA) produced by cell-free in vitro transcription from the corresponding DNA templates, encoding
the viral spike (S) protein of SARS-CoV-2.

4.4 … General recommendations
appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine. The administration of COVID-19 mRNA Vaccine BNT162b2 should be postponed in individuals suffering from acute severe febrile illness.
Individuals receiving anticoagulant therapy or those with a bleeding disorder that would contraindicate intramuscular injection, should not be given the vaccine unless the potential benefit clearly outweighs the risk of administration.
Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the vaccine.
No data are available about concomitant use of immunosuppressants.
As with any vaccine, vaccination with COVID-19 mRNA Vaccine BNT162b2 may not protect all vaccine recipients.
No data are available … for persons that have previously received a full or partial vaccine series with another COVID-19 vaccine.

4.5 Interaction with other medicinal products and other forms of interaction No interaction studies have been performed.

4.6 Fertility, pregnancy and lactation
Pregnancy: There are no or limited amount of data. Animal reproductive toxicity studies have not been completed. COVID-19 mRNA Vaccine BNT162b2is not recommended during pregnancy. For women of childbearing age, pregnancy should be excluded before vaccination. In addition, women of childbearing age should be advised to avoid pregnancy for at least 2 months after their second dose.
Breast-feeding: It is unknown whether COVID-19 mRNA Vaccine BNT162b2is excreted in human milk
Fertility: It is unknown whether COVID-19 mRNA Vaccine BNT162b2has an impact on fertility.

4.8 Undesirable effects:
The most frequent adverse reactions in participants 16 years of age and older were 
Very common = red:
pain at the injection site (>80%),
fatigue (>60%)
headache (>50%)
myalgia (>30%)
chills (>30%)
arthralgia (>20%)
and pyrexia (>10%) and were usually mild or moderate in intensity and resolved within a few days after vaccination.
Common (10%-1%):
Nausea, Redness at injection site; injection site swelling )
Uncommon (1% – 0.1%):
Lymphadenopathy, Malaise 
Rare (≥1/10,000 to <1/1,000):
Acute peripheral facial paralysis (or palsy) four participants in the COVID-19 mRNA Vaccine group
Very rare (<1/10,000): no reports

5.1 Pharmacodynamic properties ATC code: not yet assigned
[ comment: it was not published WHAT they used as a placebo in the study – probably the MenACWY vaccine against encephalitis? See below].
excluded participants who were immunocompromised
In study 2, from 44 000 participants, 21.8% were ≥ 65 years.
There were 8 confirmed COVID-19 cases from 18,242 in the COVID-19 mRNA Vaccine group,
and 162 cases in the placebo group of 18,379 respectively.
[Please see the comment: below.]

Reporting of suspected adverse reactions
…Healthcare professionals are asked to report any suspected adverse reactions via the Coronavirus Yellow Card reporting site or search for MHRA Yellow Card in the Google Play or Apple App Storeand include the vaccine brand and batch/Lot number if available

Mechanism of action:
The nucleoside-modified messenger RNA in COVID-19 mRNA Vaccine BNT162b2 is formulated in
lipid nanoparticles, which enable delivery of the RNA into host cells to allow expression of the SARSCoV-2 S antigen. The vaccine elicits both neutralizing antibody and cellular immune responses to the spike (S) antigen, which may contribute to protection against COVID-19 disease.

Confirmed cases were determined by Reverse Transcription-Polymerase Chain Reaction (RT-PCR) and at least 1 symptom consistent with COVID-19disease*.
*Case definition [of covid-19] (at least 1 of): fever, new or increased cough, new or increased shortness of breath; chills, new or increased muscle pain, new loss of taste or smell, sore throat, diarrhoea or vomiting + a positive RT-PCR test result.

5.3 Preclinical safety data …Animal studies into potential toxicity to reproduction and developmenthave not been completed

6.1 List of excipients: This vaccine contains
polyethylene glycol/macrogol (PEG) as part of ALC-0159.
ALC-0315 = (4-hydroxybutyl) azanediyl)bis (hexane-6,1-diyl)bis(2-hexyldecanoate),
ALC-0159 = 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide,
potassium chloride,
potassium dihydrogen phosphate,
sodium chloride,
disodium hydrogen phosphate dihydrate,
water for injections

6.2 Incompatibilities: In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.
Date of revision of the text: 26 January 2021

Alternative Pfizer Vaccine Analysis

Here is a fresh look at the above Pfizer trial data:
8 covid cases / 18242 x100 = 0.044% in vaccine group
162 covid cases / 18379 x100 = 0.88% in control group
WITHOUT vaccine, 0.88% of v- group = 160.5 WOULD have got covid,
That is 152.5 people (more than the 8 from 18242) = 0.836% were saved by the vaccine.
To save ONE person from covid, we needed to vaccinate 119.6 people
(NNT = “Number Needed to Treat“) [18242/152.5=119.6]
118 people did not have any benefit from the Pfizer vaccine, but all the side effects listed above under 4.8 (plus unknown long term side effects)

Looking at the POSITIVE side:
99.1% of unvaccinated people did NOT get Covid-19 disease in the Pfizer trial.

So much about the UK government information about the Pfizer COVID-19 mRNA Vaccine BNT162b2, “this temporary authorisation grants permission for the medicine to be used for active immunization to prevent COVID-19 disease caused by SARS-CoV-2 virus in individuals aged 16 years of age and over”
Further down is the same info about AstraZeneca’s vaccine: go compare:

The Defender headline: doctors link pfizer, moderna vaccines to life-threatening blood disorder
The Defender, on 9 Feb 2021

The Defender reports on 9 Feb 2021: Two women, both of whom were described as healthy before they received the Moderna vaccine… ages 72 and 48, are now being treated for immune thrombocytopenia (ITP), a condition that develops when the immune system attacks platelets (blood component essential for clotting) or the cells that create them, according to the Times….  ITP is a well-known adverse event associated with vaccinations. Pfizer said… “at this time, we have not been able to establish a causal association with our vaccine.”

Up to TOP Table of Content

Astra Zeneca COVID-19 ‘Vaccine’ ChAdOx1 S update 5 March 2021

All quotes in the white box below about the AstraZeneca vaccine are from the UK government website, selected and important passages marked in bold by

Quotes from Regulation 174 Information for UK healthcare professionals Astra Zeneca COVID-19 Vaccine (ChAdOx1 S [recombinant])
[updated 28 Jan 2021]
2. Qualitative and quantitative composition
One dose (0.5 ml) contains: COVID-19 Vaccine (ChAdOx1-S* recombinant) 5 × 10^10 viral particles (vp)
*Recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS CoV 2 Spike (S) glycoprotein. Produced in genetically modified human embryonic kidney (HEK) 293 cells.
This product contains genetically modified organisms (GMOs).

4.2 Posology and method of administration
The second dose should be administered between 4 and 12 weeks after the first dose.
Efficacy and safety data are currently limited in individuals ≥65 years of age
Safety and efficacy of COVID-19 Vaccine AstraZeneca in children and adolescents (aged <18 years old) have not yet been established. No data are available.
4.4 Special warnings and precautions for use
As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of an anaphylactic event following the administration of the vaccine.
COVID-19 Vaccine AstraZeneca should be given with caution to individuals with thrombocytopenia, any coagulation disorder or to persons on anticoagulation therapy
It is not known whether individuals with impaired immune responsiveness, including individuals receiving immunosuppressant therapy, will elicit the same response
The duration of protection has not yet been established. As with any vaccine, vaccination with COVID-19 Vaccine AstraZeneca may not protect all vaccine recipients.
This medicinal product contains less than 1 mmol sodium (23 mg) per dose

4.5 Interaction with other medicinal products and other forms of interaction: No interaction studies have been performed.
Concomitant administration of COVID-19Vaccine AstraZeneca with other vaccines has not been studied (see section 5.1).

4.6 Fertility, pregnancy and lactation:
There is a limited experience with the use of COVID-19 Vaccine AstraZeneca in pregnant women.
Definitive animal studies have not been completed yet. The full relevance of animal studies to human risk with vaccines for COVID-19 remains to be established.
Preliminary animal studies do not indicate direct or indirect harmful effects with respect to fertility.

4.8 Undesirable effects
Demographic characteristics: 9.7% were 65 years of age or older.
The most frequently reported adverse reactions were
very common (≥1/10):
injection site tenderness (>60%);
injection site pain, headache, fatigue (>50%);
myalgia, malaise (>40%);
pyrexia, chills (>30%);
and arthralgia, nausea (>20%).

The majority of adverse reactions were mild to moderate in severity and usually resolved within a few days of vaccination.
compared with the first dose, adverse reactions reported after the second dose were milder and reported less frequently.

Adverse drug reactions
Common (≥1/100 to <1/10):
 Injection site induration, influenza like illness (a)
Uncommon (≥1/1,000 to <1/100):
Blood and lymphatic system disorders: Lymphadenopathy (a)
Metabolism and nutrition disorders: Decreased appetite (a)
Nervous system disorders: Dizziness (a)
Gastrointestinal disorders: Abdominal pain (a)
Skin and subcutaneous tissue disorders: Hyperhidrosis (a), pruritus (a), rash (a)
Rare (≥1/10,000 to <1/1000): [nothing listed]
Very rare (<1/10,000):
neuroinflammatory disorders (A causal relationship has not been established.)

5.1 Pharmacodynamic properties: ATC code: J07BX03
Mechanism of action
COVID-19 Vaccine AstraZeneca is a monovalent vaccine composed of a single recombinant, replication-deficient chimpanzee adenovirus (ChAdOx1) vector encoding the S glycoprotein of SARS CoV 2.
Following administration, the S glycoprotein of SARS CoV 2 is expressed locally stimulating neutralising antibody and cellular immune responses.

Clinical efficacy:
[what happened to the COV004 group?]
control (meningococcal vaccine or saline) 
Because of logistical constraints, the interval between dose 1 and dose 2 ranged from 4 to 26 weeks.
Overall, among the participants who received COVID-19 Vaccine AstraZeneca… 5.9% [were] aged 65 or older
[in 4.8 it says: 9.7%?]
Exploratory analyses showed that increased immunogenicity was associated with a longer dose interval 
The number of COVID-19 cases (2) in 660 participants ≥65 years old were too few to draw conclusions on efficacy.
 An immunological correlate of protection has not been established; therefore the level of immune response that provides protection against COVID-19 is unknown.
[ comment: PLEASE see the copy of 2 rows of table 2 (“efficacy”) below this white box!]

6.1 List of excipients: [see photo further down]
6.2 Incompatibilities
In the absence of compatibility studies, this vaccine must not be mixed with other medicinal products.
6.6 Special precautions
The vaccine does not contain any preservative. 
COVID-19 Vaccine AstraZeneca contains genetically modified organisms (GMOs).
[AstraZeneca text revision: 06/01/2021]

———N1AstraZeneca Covid-19 Vaccine
Number of COVID-19 cases, n (%)
N2Control group
Number of COVID-19 cases, n (%)
Vaccine efficacy %
Two rows from table 2 [COVID-19 Vaccine AstraZeneca efficacy against COVID-19]
N1=5,807 N2=5,829 = Number of subjects included in each group
n = Number of subjects having a confirmed event [Covid-19 case]
COVID-19 cases30 (0.52)101 (1.73)70.42
80.63) (a)
Efficacy: the Covid-19 case difference between the vaccine and control group is
71 people = only 1.21%! [COVID-19 Vaccine AstraZeneca efficacy against COVID-19]
in the right column the vaccine efficacy is listed as 70.42%
70.42% relates to 101 control group cases, not to the 5,807 or 5,829 participants.

Alternative Analysis AstraZeneca Vaccine

Here is a fresh calculation for the trial AstraZeneca UK.gove data:
30 covid cases / 5,807 x 100 = 0.516% in vaccine group
covid cases / 5,829 x100 = 1.73% in control group
WITHOUT vaccine, 1.73% of the vaccine group = 100.5 WOULD have got covid
that is 70.5 people more (than the 30 from 5807) = 1.21% saved by the vaccine.
To save ONE person from covid, we need to vaccinate 82.4 people
(NNT = “Number Needed to Treat”)
[5807 / 70.5 = 82.37]
81 people did not have any benefit from the AstraZeneca vaccine, but all the side effects listed above under 4.8 (plus unknown long term side effects)

Looking at the POSITIVE side:
98.3% of unvaccinated people did NOT get Covid-19 disease in the AstraZeneca trial.

part of printed patient information of the ChAdOx1-S covid-19 vaccine from Astra Zeneca
January 2021
Printed patient information of the ChAdOx1-S covid-19 vaccine from Astra Zeneca.
For more information see below in this chapter.

Up to TOP Table of Content

Pfizer, EU ‘Tozinameran‘ & Israel updated 25 Feb 2021

Here is some interesting information from Europe:

Pfizer vaccine Tozinameran in Europe cases = side effects show:
vast majority are care workers and female adults younger than 65
30 Jan 2021: a sad record of side effects of Pfizer’s covid-19 vaccine in Europe under the brand name “Tozinameran” shows the huge number of health care workers affected – nearly 4x more women then men suffer side effects (probably due to the high percentage of female nurses and carers who had to take the vaccine?)

22 Feb 2021: Below is a summary of an analysis: “The uncovering of the vaccination data in Israel reveals a frightening picture נקים של הודעות

“We conclude that the Pfizer vaccines, for the elderly, killed during the 5-week vaccination period about 40 times more people than the disease itself would have killed, and about 260 times more
people than the disease among the younger age class
” [source]

Those below 13… have an increased adverse reaction rate, including death, to vaccines as shown by multi-decennial data from the VAERS reports in the USA.” [19 Feb 2021]

Israel death rate is 40x higher after rollout of Pfizer covid-19 vaccine
One of the speakers in the Video above presented this summary

Those below 13… have an increased adverse reaction rate, including death, to vaccines

Introducing COMIRNATY®, the EU Brand Name for Pfizer & BioNTech’s COVID-19 Vaccine [28 Dec 2020]
BioNTech and Pfizer commented on the vaccine’s brand name, “The vaccine will be marketed in the EU under the brand name COMIRNATY®, which represents a combination of the terms COVID-19, mRNA, community and immunity, to highlight the first authorization of a messenger RNA (mRNA) vaccine, as well as the joint global efforts that made this achievement possible with unprecedented rigor and efficiency, and with safety at the forefront”
The COVID-19 vaccine’s proposed nonproprietary name (pINN), tozinameran (toe zi na’ mer an), was also developed by Brand Institute and its wholly owned subsidiary, Drug Safety Institute [see table above]

Up to TOP Table of Content

Better 12 Weeks Apart updated 15 Feb 2021

On 30 December the four UK chief medical officers announced that the second doses of the covid vaccines should be given towards the end of 12 weeks rather than in the previously recommended 3-4 weeks. “The trials of the Oxford-AstraZeneca vaccine did include different spacing between doses, finding that a longer gap (two to three months) led to a greater immune response,”
Both vaccines “offer considerable protection after a single dose, at least in the short term.”
In its “green book” Public Health England said that during the phase III trial most of the vaccine failures were in the days immediately after the first dose, indicating that the short term protection starts around day 10.6
Looking at the data from day 15 to 21, it calculated that the efficacy against symptomatic covid-19 [after the first injection] was around 89%

covid-19 vaccine efficacy shows maximum after 12 weeks in trial
This graphic on page 31 on the study “Single dose administration, and the influence of the timing…” looks complicated – the efficacy (hollow dots) starts below zero in the first days and keeps increasing with time.

1 Feb 2021: “Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine” [The Lancet]:
Vaccine efficacy after a single standard dose of vaccine from day 22 to day 90 post vaccination was 76% (59%, 86%), and modelled analysis indicated that protection did not wane during this initial 3 month period.
Antibody levels were maintained during this period with minimal waning by day 90″
Immunogenicity data showed binding antibody responses more than 2-fold higher after an interval of 12 or more weeks compared with and interval of less than 6 weeks.” comment: the “Conflict of Interest” paragraph of the above quoted paper looks impressively long…

Coronacast 11: Will vaccines roll out when the pandemic is over?
Info video from 4 Dec. 2020 – on
Video + TRANSCRIPT on…

4 December: Since the above video was recorded, the BioNTech/Pfizer vaccine composition, including the nanoparticle composition, has been released by the MHRA but it does not include concentrations of ingredients making it impossible to assess toxicology. The ingredients will include 30 micrograms mRNA in each dose, along with:

  • ALC-0315 = (4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate),
  • ALC-0159 = 2[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide,
  • 1,2-Distearoyl-sn-glycero-3-phosphocholine,
  • cholesterol,
  • potassium chloride,
  • potassium dihydrogen phosphate,
  • sodium chloride,
  • disodium hydrogen phosphate dihydrate,
  • sucrose.

Above text, the video + detailed transcript are on

Quotes from the NHA video transcript above:
“It’s essential that all known risks, relating both to the pathogen but also to the particular vaccine in question, are put in the public domain…
That means putting the raw data into the public domain so it can be analysed by independent scientists.
To-date, none of the full datasets have been released.
“The only things we’ve got to go on so far are press releases that are deeply deficient in data on both risks and benefits.”
History tells us it can be years before safety concerns are exposed, as we discovered with the swine flu vaccine Pandemrix and narcolepsy in children.” conclusion: it is common sense not to overburden the immune system with more than one lot of vaccine ingredients at a time, but leave plenty (the more, the better) of time between each vaccine to allow the body to detox various vaccine ingredients.
It would be wise to use the time before a second shot to analyse what others have experienced, and check the outcome of the animal tests.

Up to TOP Table of Content

Prion Disease & Pfizer Vaccine updated 1 March 2021

Definition: “Prion diseases (or transmissible spongiform encephalopathies) are a group of uniformly fatal neurodegenerative diseases characterised by progressive dementia and motor dysfunction. These diseases occur in spontaneous, genetic, and acquired forms. Patients commonly present with behavioural or personality changes, myoclonus, visual disturbances, movement problems, and/or incoordination. Survival from first symptom is typically <1 year in sporadic and acquired cases.” [British Medical Journal 27 Feb 2020]

COVID-19 RNA Based Vaccines and the Risk of Prion Disease
[research article 27 Dec 2020]
“Development of new vaccine technology has been plagued with problems in the past. The current RNA based SARSCoV-2 vaccines were approved in the US using an emergency order without extensive long term safety testing. In this paper the Pfizer COVID-19 vaccine was evaluated for the potential to induce prion-based disease in vaccine

“The RNA sequence of the vaccine as well as the spike protein target interaction were analyzed for the potential to convert intracellular RNA binding proteins TAR DNA binding protein (TDP-43) and Fused in Sarcoma (FUS) into their pathologic prion conformations.
The results indicate that the vaccine RNA has specific sequences that may induce TDP-43 and FUS to fold into their pathologic prion confirmations…”
The spike protein, created by the translation of the vaccine RNA, binds angiotensin converting enzyme 2 (ACE2), a zinc containing enzyme. This interaction has the potential to increase intracellular zinc. Zinc ions have been shown to cause the transformation of TDP-43 to its pathologic prion configuration. The folding of TDP-43 and FUS into their pathologic prion confirmations is known to cause ALS, front temporal lobar degeneration, Alzheimer’s disease and other neurological degenerative diseases. The enclosed finding as well as additional potential risks leads the author to believe that regulatory approval of the RNA based vaccines for SARS-CoV-2 was premature and that the vaccine may cause much more harm than benefit

Up to TOP Table of Content

Nanoparticles updated 25 Dec 2020

The ALC-0315 (4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) is a hexane containing compound and these are known to be potentially neurotoxic.
ALC-0159 = 2[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide contains polyethylene glycol (PEG) that is associated with hypersensitivity and allergenic reactions.
The toxicological profile of the mRNA delivery system cannot be determined because neither have the concentrations been declared, nor has the nanoparticle delivery system, surface charges and other physicochemical characteristics been declared. These may dramatically increase the toxicological profile. [source]

The covid-19 vaccine is not a fragment of a microorganism being injected to achieve immunity and a reduction in disease transmission.Instead it is a piece of synthetic genetic code being delivered to the nucleus of the cell via nanotechnology and is therefore genetic engineeringIt does not produce immunity and it does not prevent disease transmission.This meets the legal definition of a “medical device: it does not meet the legal definition of a “vaccine”.” [21 January 2021 Anna de Buisseret]

Evening standard headline:
warning after 2 NHS workers have allergic reactions to Pfizer  covid vaccine
“…They developed symptoms of “anaphylactoid reaction” shortly after receiving the vaccine…”
“Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer BioNTech vaccine. A second dose should not be given to anyone who has experienced anaphylaxis following administration of the first dose of this vaccine.” [Evening Standard, 10 December]

21 Dec 2020: Suspicions grow that nanoparticles in Pfizer’s COVID-19 vaccine trigger rare allergic reactions
Severe allergy-like reactions in at least eight people who received the COVID-19 vaccine produced by Pfizer and BioNTech over the past 2 weeks may be due to a compound in the packaging of the messenger RNA (mRNA) that forms the vaccine’s main ingredient.”
Polyethylene glycol (PEG) has never been used before in an approved vaccine, but it is found in many drugs that have occasionally triggered anaphylaxis—a potentially life-threatening reaction that can cause rashes, a plummeting blood pressure, shortness of breath, and a fast heartbeat. Some allergists and immunologists believe a small number of people previously exposed to PEG may have high levels of antibodies against PEG, putting them at risk of an anaphylactic reaction to the vaccine.” [More on]

Children’s Health Defense reportsmRNA vaccines undergoing Covid-19 clinical trials, including the Moderna vaccine, rely on a nanoparticle-based “carrier system” containing a synthetic chemical called polyethylene glycol (PEG).
The use of PEG in drugs and vaccines is increasingly controversial due to the well-documented incidence of adverse PEG-related immune reactions, including life-threatening anaphylaxis.
Roughly seven in ten Americans may already be sensitized to PEG, which may result in reduced efficacy of the vaccine and an increase in adverse side effects.
If a PEG-containing mRNA vaccine for Covid-19 gains FDA approval, the uptick in exposure to PEG will be unprecedented—and potentially disastrous.
PEG is used in drugs, for example in Bayer’s laxative MiraLAX (a medication used for constipation). Many parents of chronically constipated children have accused MiraLAX of provoking severe neuropsychiatric symptoms in their offspring, including mood swings, rage, phobias and paranoia.

Up to TOP Table of Content

FDA Safety Concerns updated 25 Oct 2020

screenshot: FDA in the US has published their vaccine side effects draft on page 16
On 22 October the FDA in the US has published their vaccine side effects draft on page 16: For the UK, read on below:
newspaper headline: 
FDA: six people die during Pfize/Biotech's coronavirus vaccine trials
Six people died during trials of the coronavirus vaccine produced by the American pharmaceutical company “Pfizer” and the German “BioNTech” company, the US Food and Drug Administration (FDA) said on Wednesday.

In a statement released by US channel Al-Hurra, the FDA confirmed that among the deceased was a participant who was obese and suffering from arteriosclerosis and died three days after taking the first dose of the vaccine.
The FDA added that two participants died from heart attacks or stroke…
“Of the six dead, three are over the age of 55,” the FDA clarified. [source]

Up to TOP Table of Content

Questioning Vaccine Trials updated 13 Feb 2021

Del Bigtree shows covid vaccine trial monitoring begins only after 41 days
On the 3rd December, Del Bigtree from TheHighWire reveals shocking details of the covid-19 vaccine trials: they only count side effects from day 42 after the 1st vaccine

Dr. Wodarg and Dr. Yeadon request a stop of all corona vaccination studies and call for co-signing the petition [1 December 2020]
The concerns are directed in particular to the following points:
– The formation of so-called “non-neutralizing antibodies” can lead to an exaggerated immune reaction, especially when the test person is confronted with the real, “wild” virus after vaccination. This so-called antibody-dependent amplification, ADE, has long been known from experiments with corona vaccines in cats, for example. In the course of these studies all cats that initially tolerated the vaccination well died after catching the wild virus.
 The vaccinations are expected to produce antibodies against spike proteins of SARS-CoV-2. However, spike proteins also contain syncytin-homologous proteins, which are essential for the formation of the placenta in mammals such as humans. It must be absolutely ruled out that a vaccine against SARS-CoV-2 could trigger an immune reaction against syncytin-1, as otherwise infertility of indefinite duration could result in vaccinated women.
– The mRNA vaccines from BioNTech/Pfizer contain polyethylene glycol (PEG)70% of people develop antibodies against this substance – this means that many people can develop allergic, potentially fatal reactions to the vaccination.
– The much too short duration of the study does not allow a realistic estimation of the late effects. As in the narcolepsy cases after the swine flu vaccination, millions of healthy people would be exposed to an unacceptable risk if an emergency approval were to be granted and the possibility of observing the late effects of the vaccination were to follow. Nevertheless, BioNTech/Pfizer apparently submitted an application for emergency approval on December 1, 2020.

Syncytin-1 is a protein that functions for placental development and therefore is essential for fertility. Fifteen years ago, it was proposed that a synthetic Syncytin-1 vaccine could be developed as a contraceptive that would work to produce antibodies against human Syncytin-1. [59]” [source]

Dr. Mike Yeadon, Pfizer’s former Vice President and Chief Scientist for Allergy & Respiratory [November 23]:
Dr. Michael Yeadon, who “spent over 30 years leading new [allergy and respiratory] medicines research in some of the world’s largest pharmaceutical companies,” and retired from Pfizer with “the most senior research position in this field,” wrote:

“There is absolutely no need for vaccines to extinguish the pandemic. I’ve never heard such nonsense talked about vaccines. You do not vaccinate people who aren’t at risk from a disease. You also don’t set about planning to vaccinate millions of fit and healthy people with a vaccine that hasn’t been extensively tested on human subjects.” [Dr. Mike Yeadon]

In the article Will covid-19 vaccines save lives? Current trials aren’t designed to tell us (21 Oct) the British Medical Journal BMJ writes:
To the public this seems fairly obvious. “The primary goal of a covid-19 vaccine is to keep people from getting very sick and dying,”
The current phase III trials are not actually set up to prove either (table 1). None of the trials currently under way are designed to detect a reduction in any serious outcome such as hospital admissions, use of intensive care, or deaths. Nor are the vaccines being studied to determine whether they can interrupt transmission of the virus.”
“Hospital admissions and deaths from covid-19 are simply too uncommon in the population being studied for an effective vaccine to demonstrate statistically significant differences in a trial of 30 000 people.”

the Defender headline 9 Feb 2021: 
Immunologist: Pfizer, Moderna Vaccines Could Cause Long-Term chronic Illness
Children’s Health Defense reports on 9 February 2021

In a new research article published in Microbiology & Infectious Diseases, veteran immunologist J. Bart Classen expresses similar concerns and writes that “RNA-based COVID vaccines have the potential to cause more disease than the epidemic of COVID-19.” Classen warns that the RNA-based vaccine technology could create “new potential mechanisms” of vaccine adverse events that may take years to come to light.

Classen summarises his research article with
The spike protein encoded by the vaccine binds angiotensin
converting enzyme 2 (ACE2), an enzyme which contains zinc
molecules [8]. The binding of spike protein to ACE2 has the
potential to release the zinc molecule, an ion that causes TDP-43
to assume its pathologic prion transformation
Referring to the 2001 anthrax threat, Classen concludes: “
“The vaccine could be a bioweapon and even more dangerous than the original infection.”

Up to TOP Table of Content

Vaccine / Immune Enhancement
(Pathogenic Priming) updated: 15 Dec 2020

Researchers have tried to develop SARS vaccines in the past, resulting in “vaccine enhancement“, where the vaccine makes the disease worse when a vaccinated person is infected with the virus.
5 minute video: “Dr. Fauci and COVID-19 Priorities:
Therapeutics Now or Vaccines Later?” on

Pfizer COVID vaccine trial shows alarming evidence of pathogenic priming in older adults (11 Dec 2020):
There’s been a serious terminology problem with “immune enhancement” which sounds like something helpful to the immune system.  In fact, it is quite the opposite. The problem is, in reality “disease enhancement”. Disease enhancement now appears to be caused by initial exposure to a pathogen’s proteins, or parts of proteins, which primes the body to autoimmunity. That is “pathogenic priming.” In COVID-19, every protein in the SARS-CoV-2 has at least one epitope that matches human proteins someplace in the human body. About one-third of the epitopes in SARS-CoV-2 virus that match human proteins match immune system proteins
The short-term study excludes any means of detecting whether the initial exposure may play a fundamental root cause role in setting up patients for life-long chronic illness.
More serious adverse events were seen with the second dose.

A 10-fold increase of serious adverse events
on second dose in older adults on second dose, compared to 3.6-fold for those under 55 

Professor Jonathan Heeney, Head of the Laboratory of Viral Zoonotics at the University of Cambridge, saidIf you make antibodies against the spike, they can end up binding to it and helping the virus invade important immune cells known as monocyte-macrophages. Rather than destroying the virus, these cells can then end up being reprogrammed by the viruses, exacerbating the immune response and making the disease much, much worse than it would otherwise be.”

Children’s Health Defense Team reports on 25 Sept:
38 Covid-19 vaccines are undergoing clinical evaluation. “Oxford and AstraZeneca called a temporary halt to their clinical trials in five countries. The brief hold was prompted by a UK participant’s report, after her second dose of vaccine, of a serious adverse event—a demyelinating condition called transverse myelitis (TM) associated with pain, muscle weakness, paralysis and bowel and bladder problemsTwo-thirds of those who experience TM remain permanently disabled.

AstraZeneca also disclosed that the September pause was actually the second time-out in two months. The first incident, which initially went unpublicized [until it was leaked], occurred in July when another UK participant experienced TM after one dose of vaccine and ended up with a brand-new diagnosis of multiple sclerosis (MS).”

The Hal Turne Radio Show adds (20 Sept): According to sources who claim to be familiar with the vaccine trials, the second volunteer suddenly started saying “They’ve killed God; I can’t feel God anymore – my Soul is dead” after the vaccine.

The trial’s Patient Information Sheet (11 Sept) writes:
The vaccine tested in the above mentioned research study is “ChAdOx1 nCoV-19” made from a virus (ChAdOx1), which is a weakened version of a common cold virus (adenovirus) from chimpanzees that has been genetically changed. To this virus genes are added that make proteins from the COVID-19 virus called Spike glycoprotein (S).
we are hoping to make the body recognise and develop an immune response to the Spike protein that will help stop the SARS-CoV-2 virus from entering human cells”
We are not sure what dose of vaccine is most likely to be protective”
we don’t know how much of an immune response is needed for protection”
We don’t know which dose, if any, will provide protection.”

The control (comparison) group is NOT a placebo, but MenACWY, a licensed vaccine against group A, C, W and Y meningococcus (MenACWY) as an ‘active control’ vaccine.
MenACWY has been given routinely to teenagers in the UK since 2015 against one of the most common causes of meningitis and sepsis.

“by comparing COVID-19 disease rates, immune responses and post-vaccination symptoms between participants receiving ChAdOx1 nCoV-19 and MenACWY we will get a better understanding of how well ChAdOx1 nCoV-19 is working.” [source]

Reuters headline 21 Oct 2020
AstraZeneca Covid-19 vaccine trial Brazil volunteer dies, trial to continue
Reuters reports: “SAO PAULO/FRANFURT – Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca AZN.L and Oxford University had died but added that the trial would continue.” (21 October 2020)

Up to TOP Table of Content

Covid “Vaccine” Trials Rigged? updated 15 Nov 2020

How COVID-19 Vaccine Trials Are Rigged” (27 October)
“those receiving the vaccine in these trials are young and healthy individuals
“the way trial protocols are designed suggests these vaccines will not have a significant impact on infection rates, hospitalizations or deaths.
The only criterion for a successful COVID-19 vaccine is a reduction of symptoms shared by both COVID-19 and the common cold.
In AstraZeneca’s case, the interim analysis includes 50 vaccine recipients. The vaccine will be a success if 12 or fewer develop symptoms after exposure to SARS-CoV-2, compared to 19 in the 25-person control group.
Three of the vaccine protocols — Moderna, Pfizer, and AstraZeneca — do not require that their vaccine prevent serious disease only that they prevent moderate symptoms which may be as mild as cough, or headache” 
each study intends to complete interim and primary analyses that at most include 164 participants.” [normally trials would range from 30,000 to 60,000!]
Moderna’s success margin is for 13 or less of those 53 to develop symptoms
These trials all clearly focus on eliminating symptoms of COVID-19, and not infections
“AstraZeneca is masking potential side effects is by administering the vaccine along with certain drugs. In one of its study arms, subjects are given acetaminophen every six hours for the first 24 hours after inoculation.”
one-third of people vaccinated with the COVID-19 vaccine without acetaminophen experienced moderate or severe chills, fatigue, headache, malaise, and/or feverishness...
That’s a lot, in a young and healthy group of people
after the first of two doses of the Moderna COVID-19 vaccine,
80% of Phase 1 participants receiving the 100 microgram (mcg) dose developed systemic side effects.21
After the second dose, 100% reported side effects ranging from fatigue (80%), chills (80%), headache (60%) and myalgia or muscle pain (53%).
“One of the participants in Pfizer’s vaccine trial “woke up with chills, shaking so hard he cracked a tooth after taking the second dose.”
“some COVID-19 vaccine candidates might put certain people at a higher risk of acquiring HIV, the virus that causes AIDS.26,27,28
“the trial designs are such that the vaccines will get a passing grade even if their efficacy is minimal.” [source]

Jon Rappoport reports on 11 Nov:
“According to the protocols for their studies, … a vaccine could meet the companies’ benchmark for success if it lowered the risk of mild Covid-19, but was never shown to reduce moderate or severe forms of the disease, or the risk of hospitalization, admissions to the intensive care unit or death.”
The trials are designed to show effectiveness in preventing mild cases of COVID, which nobody should care about, because mild cases naturally run their course and cause no harm. THERE IS NO NEED FOR A VACCINE THAT PREVENTS MILD CASES.
Jon’s blog refers to an “opinion piece” in the New York Times.

UK Dept. of Health & Social Care Open consultationChanges to Human Medicine Regulations to support the rollout of COVID-19 vaccines We are asking for comments by the end of Friday 18 September 2020.” AFTER this deadline, if you have grave concerns, especially if you are a stake holder in the community. you can still contact us at

meme: I really hope they count every death within 28 days of vaccination as a vaccine death.

Here is the study from April 2012: “Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus
“…challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated.”

Up to TOP Table of Content

Ecological damages updated 1 Dec 2020

Drug maker GlaxoSmithKline may need to slaughter half a million sharks to harvest squalene, an oil made in shark livers, to make a new line of COVID jabs. Glaxo mixes squalene with a witches’ brew of proprietary surfactants to produce its controversial AS03 vaccine adjuvant. Adjuvants… are associated with a variety of autoimmune diseases. Scientific studies have linked squalene adjuvants to Gulf War syndrome and to a wave of debilitating neurological disorders including epidemics of narcolepsy. [source]
A recent study links squalene to carcinomas.

National Georgaphics reports (5 Nov 2020): Horseshoe crab blood is key to making a COVID-19 vaccine—but the ecosystem may suffer. Conservationists worry the crustaceans, which are vital food sources for many species, will decline in number. These crustaceans’ milky-blue blood provides the only known natural source of limulus amebocyte lysate, a substance that detects a contaminant called endotoxin. If even tiny amounts of endotoxin—a type of bacteria—make their way into vaccines, injectable drugs, or other sterile pharmaceuticals such as artificial knees and hips, the results can be deadly.
“All pharmaceutical companies around the world rely on these crabsAs many as 30 percent of the bled crabs ultimately died

Up to TOP Table of Content

Law Offenses & Violations: updated: 15 Jan 2021

Can we trust the vaccine producers?
The “Corporate Research Project” produced
“Rap Sheets” for the these companies:
• Pfizer
• AstraSeneca

For example Pfizer:
In the area of product safety, Pfizer’s biggest scandal involved defective heart valves sold by its Shiley subsidiary that led to the deaths of more than 100 people… the company had deliberately misled regulators about the hazards. Also on Pfizer’s list of scandals are a 2012 bribery settlement; massive tax avoidance; and lawsuits alleging that during a meningitis epidemic in Nigeria in the 1990s the company tested a risky new drug on children without consent from their parents.
“…scores of patients died from acute liver failure said to be caused by the drug [Rezulin].
In 2008 Pfizer announced that it was setting aside $894 million to settle the lawsuits that had been filed in connection with Bextra and Celebrex.
An article in the Saturday Review in 1957 denounced the company for tactics such as running ads for its antibiotics that displayed the names of doctors who were supposedly endorsing the product but who turned out to be fictitious.
In 1976 Pfizer was one of the many companies that disclosed that it had made questionable payments to foreign government officials. The company said that about $265,000 had been paid to officials in three countries

In 2004 Pfizer’s Warner-Lambert subsidiary agreed to pay $430 million to resolve criminal and civil charges that it paid physicians to prescribe its epilepsy drug Neurontin to patients with ailments for which the medication was not approved.
In 2009 Pfizer agreed to pay $2.3 billion to resolve criminal and civil charges relating to the  improper marketing of Bextra and three other medications.
In 2010 Pfizer disclosed that during a six-month period the previous year it had paid $20 million to some 4,500 doctors and other medical professionals for consulting and speaking on the company’s behalf.
Environmental groups in New Jersey have criticized as inadequate a clean-up plan devised by Pfizer and the EPA for the American Cyanamid Superfund site in Bridgewater, which is considered one of the worst toxic waste sites in the country.
…and the list goes on – More on

AstraZeneca violation tracker table shows penalies paid
The Violation Tracker for AstraSeneca shows total Penalties of $1,148,775,284
since 2000. The Pfizer Violation Tracker, totals over 4x more: $4,712,210,359

Up to TOP Table of Content

Virus Mutations updated: 20 Sept. 2020

A world wide SARS-CoV-2 lineages tracing of about 79 000 samples in over 80 countries since 24 December 2019 shows, that after six months the original Wuhan virus has mutated into 100 lines, named Lineage A and Lineage B.
Johannes Kreis believes, the original virus is not around any more (SARS-CoV2 – in 6 Monaten über 100 verschiedene Virenstämme).
By the end of 2020 we can assume that covid-19 will have mutated into over 200 strands.

This study shows SARS-CoV-2 genome mutations (4 March 2020)
This study shows SARS-CoV-2 genome mutations (4 March 2020)

Another study: 2019 Novel Coronavirus Is Undergoing Active Recombination (4th of March) found that “the SARS-CoV-2 haplotype network has obvious characteristics of single origin from haplotype hap_011: (1) the network is star-like, centralized on the haplotype hap_011; (2) hap_011 has the largest sample size and the majority of the samples are from Hubei province, where the outbreak originated… The single origin of SARS-CoV-2 indicates that persistent animal-to-human transmission is unlikely; otherwise, multiple nodes with the above characteristics should be observed…
This report provides the first evidence for genetic recombination—a new way of evolution besides mutation in SARS-CoV-2.” 

That means: occasionally different virus mutations interact with each other, causing new recombined strands with unknown characteristics.

Covid-19 is an RNA virus, like the flu and measles, famous for their rapid and numerous mutations compared with DNA viruses, such as herpes, smallpox, and human papillomavirus (HPV).
It is their very nature to mutate – more likely into a weaker version (which is observed in August, that despite new “cases” surging, covid death numbers keep falling). 
Mutations commonly appear and die out again quickly.

This means that every vaccine will always be multiple generations behind, and therefore per definition outdated.
Dr. Mark Schleiss, a pediatric infectious disease specialist and investigator with the Institute for Molecular Virology at the University of Minnesota, says‘In the world of RNA viruses, change is the norm. We expect RNA viruses to change frequently. That’s just their nature.’
But possible life long immune system troubles caused by a vaccine may stay with us.

Up to TOP Table of Content

Vaccine Development updated 15 Feb 2021

A “safe” vaccine needs at least five years to develop.
If the vaccine works with young healthy volunteers (who might not even need it), it is no proof that it will be of any benefit to the oder generation, especially those with underlying conditions.
We might find severe auto-immune side effects of the vaccine, and possibly reduced fertility in the next generation.
Dr. Kendrick in an interviewThey have been trying to get a vaccine for HIV for the last 30 years and they have not managed it yet. There is a reason for that, and it is probably the same reason why they will not get a vaccine for this.”
Shibo Jiang in ‘nature’“I have worked to develop vaccines and treatments for coronaviruses since 2003, when the severe acute respiratory syndrome (SARS) outbreak happened… Safety always comes first.
“Standard protocols are essential for safeguarding health. Before allowing use of a COVID-19 vaccine in humans, regulators should evaluate safety with a range of virus strains and in more than one animal model. They should also demand strong preclinical evidence that the experimental vaccines prevent infection.”
“the old saying holds: measure twice, cut once.”

Global analytics firm Clarivate took a look at vaccines from two companies that have entered clinical trials—Moderna and Inovio—and came to a sobering conclusion: It will take at least five years for either vaccine candidate to complete the development process through full regulatory approval. Using a tool it developed called Cortellis Analytics, Clarivate estimated that Moderna currently has just a 5% probability of success with its COVID-19 vaccine mRNA-1273, and that the time window for approval would be 5.2 years. 
The other vaccine candidate that Clarivate evaluated was Inovio’s DNA vaccine INO-4800, which the company moved into clinical testing last week. Clarivate forecasts a probability of success of 15% for INO-4800 and an approval timeline of 5.5 years.
As of April 8 there are 185 companies and research institutes working on 156 COVID-19 medicines and vaccines. [, 17 April 2020]

Wuhan peptide 22 and
HERV-K peptide 22 comparison shows similarity and raises fertility concerns
Concerns of fertility are addressed by Dr. Wolfgang Wodarg in TheHighWire on 3 December (after one hour into the news), as the covid-19 vaccine targets the proteine 22, which looks very similar to the proteine which is essential for building the placenta boundary when a woman becomes pregnant (syncytin-homologous protein).

Below is a VERY interesting enquiry about the virus used to develop the Pfizer vaccine:

EMAIL EXCHANGE Frances Leader WITH UK MHRA - Exposes the DNA template used does not come from an isolated virus from an infected person
EMAIL EXCHANGE WITH UK MHRA – Exposing the genomic sequence of SARSCov2
First email reponse


Frances Leader writes in her HIVE BLOG:
“When I read the Wuhan study in Feb 2020 I was mortified by the monkey kidney & foetal cell-lines which were used as a “culture” before rt-PCR amplification. Isolation was never satisfactory at any stage thereafter. I honestly felt sick.
The genome sequence was computed from this.
I set about proving that the vaccine has been created from a computer generated genomic sequence & not one isolated from an infected person, either in Wuhan or anywhere else in the world since.”

The DNA template (acute respiratory syndrome coronavirus2,GenBank: MN9089473) was generated via a combination of gene synthesis and recombinant DNA technology [MHRA]

EMAIL EXCHANGE Frances Leader WITH UK MHRA - Exposes the genomic sequence of SARSCov2 DNA template
EMAIL EXCHANGE WITH UK MHRA – Exposing the genomic sequence of SARSCov2
Second email response

By the time the Covid-19 vaccine was rolled out from December 2020, the actual virus SARS-CoV-2 has become insignificant and not virulent any more, and the majority of the population has already gained natural immunity.

Interesting timing of previous vaccine introductions:

the timing of vaccine introduction for whooping cough, diphteria, measles and polio shows it was introduced after the cases went right down
An old strategy: when “it is all over”, a vaccine is introduced,
and we might be told the vaccine “eradicated” the disease.

Up to TOP Table of Content

Early Safety Warnings updated 15 Oct 2020

Children’s Health Defense reports: The coronavirus vaccine producer ‘Moderna’ chose Haydon (like the other volunteers) for the study because of the robust good health. He was among the 15 volunteers in the high dose group. Within 45 days, three of these—a shocking 20%—experienced “serious” adverse events according to Moderna’s press release meaning they required hospitalization or medical intervention. Less than 12 hours after vaccination, Hayden suffered muscle aches, vomiting, spiked a 103.2 degree fever and lost consciousness. 

Dr. Mercola writes in an analysis on 9 October:
“Offit warns there could be problems with Moderna’s and BioNTech’s messenger RNA (mRNA) vaccines because they have extraordinary shipping and handling needs that include using dry ice. “We’ve never done that before in this country,” he told MarketWatch.15 “Never.”

Below is a STRONG warning what could happen if people get a flu vaccine AND a second vaccine (like the coronavirus vaccine) in the same season: the deaths rate could rise significantly:

diagram shows Flu vaccine deaths according to the US VAERS spiked in 2010 when a second vaccine against Swine Flu was given.
Flu vaccine deaths according to the US VAERS spiked in 2010
when a second vaccine against Swine Flu was given.
This is a warning what is likely to happen if people who got the flu shot
will receive an additional vaccine against coronavirus.
chart presented by Brian Hooker, CDC whistle blower

Here is the transcript of an experts discussion about the coronavirus vaccine (developed by Moderna, Bill Gates’ favoured company). Some quotes:
This is an experimental technology that has never been done before in history. What is does, it injects a snippet of the virus that carries a genetic code in its RNA that is designed to alter the DNA, the code in every cell in your body to get your body to naturally start producing those antigens.”
“It is genetic engineering. It has been condemned by the Geneva Statement because those genetic changes will survive in your sperm and they will live in your children or in your ovaries.”
“Here’s what happened. After the SARS epidemic in 2002…SARS was a kind of coronavirus. they developed about thirty different vaccines, and they chose the four most promising models. They tested them on ferrets which are the animal that is most analogous to human reaction to upper respiratory infection. They’re very similar to humans. They’re very predictive of what’s going to happen in human beings.”
When those ferrets were later exposed to the wild virus, they all had body wide inflammation in all their organs, and they died.”

Up to TOP Table of Content

Is This The End? updated 28 Feb 2021

Where might this all end? 
Here is a thought provoking article:
Will New COVID Vaccine Make You Transhuman? Some quotes:

The goal of the transhumanist movement, or “Human 2.0”, is to transcend biology into technology, to meld human biology with technology and artificial intelligence

Right now, today, we may be standing at the literal crossroads of transhumanism, thanks to the fast approaching release of one or more mRNA COVID-19 vaccines

COVID-19 mRNA vaccines are designed to instruct your cells to make the SARS-CoV-2 spike protein. It does this through a process called transfection, which is also used to create genetically engineered organisms

Transfection can have either temporary or permanent effects on the genome, and it is unclear how the COVID-19 vaccines may affect the human genome long-term

In 2019, researchers discovered the 2009 pandemic swine flu vaccine Pandemrix caused narcolepsy by affecting a non-coding RNA gene that regulates the production of glial cell line-derived neurotrophic factor, a protein that plays an important role in neuronal survival. If a conventional vaccine can have genetic effects, the risk of mRNA vaccines having genetic effects is bound to be even greater.

Thank you for having read so far. Let us remember:
there is ALWAYS hope. If you are worried about infertility (spike S protein and placenta discussion) after being vaccinated:
here is proof that unexpected things can happen:
The Pfizer mRNA vaccine resulted in TWO pregnancies!

Pfizer vaccine adverse effect: 
2 pregnancies and 5 spontaneous abortions by 31 January 2021
This is probably not an immaculate conception – but more likely a result of a failure of the anti baby pill. Screen shot mRNA PfizerBioNTech analysis print cumulative total by 31 January 2021

Keep your humour…
Below is a photo of a fresh new approach to the vaccine discussion:

I've come up with a vac scene
Will machines and robots replace humanity in the future?

Up to TOP Table of Content

Comment by posted 5 March 2021

Any covid vaccine (or “gene therapy”) has a risk.
How high that is, we don’t know; it can take many months and years
until side effects will show. Are we walking into a genetic mine field, reprogramming human body cells?
Will it alter our genetic figerprint?
Will our very own unique DNA change?
Might that alter our personality?
Could it be that our subtle “vibration” changes?
Is there a possibility of a disconnection between body and soul?
Will it affect fertility – and the health of the next generation?
We will see. Dr. Shery Tenpenny estimates that many will die half a year after the shot.
The real tragedy is not that some old and frail people or those who have ruined their health and their immune system will die prematurely;
they had their lives.
The real danger for the survival of the human race arises, if young people and children, the next generation, our hope and future might get injected.
On a sinking ship it is always:”women and children first!”
No fertile man, woman or child should get “the vaccine”.

What’s the choice, if not “the vaccine”?
Answer: We Need To Focus On The Immune System, which kept the human race alive, healthy and strong for millenia.
What about covid?
The danger of dying with covid-19 symptoms has ben highly exaggerated. Death tolls in 2020 were in the range of previous years; the death labels and statistics were manipulated spread via the main stream media, as shown in Did We Get It All Wrong Fighting The Virus?
Chances of getting covid-19 symptoms and dying from them are actually very low.
I can’t believe this.”
Here are some steps helping you to challenge your belief:
1) Make an experiment and stop watching ANY TV or radio programme for a week – and do NOT read ANY “news”paper.
Connect with nature, animals and real people instead.
2) Study health and healthy living. Find sources not directly or indirectly influenced by the pharmaceutical industry.
3) Read about psychological ways of manipulation

The biggest challenge in 2021 is to be and stay human.
Bless you!

Up to TOP Table of Content  *  Contact

UK Covid Vaccines Data ARCHIVE updated 25 June 2021

UK Yellow Card reports published Thu 8 April
Data by 28-Mar TOTAL reports / reactions / fatalities
AstraZeneca: 116 162 / 440871 / 472
[=> 51 deaths in the last week & 3.7 mio vaccinated]
Pfizer: 43491 / 124371 / 302
[=> 19 deaths in one week & 0.1 mio were vaccinated
+ 3.7 million second doses, mostly the Pfizer]
unspecified: 418 / 1367 / 12
[ => 3 deaths last week]
UK total vaccine fatalities reported: 786
[=> 73 deaths in the last week]
“In the week since the previous summary for 21 March 2021 we have received a further 2,608 Yllow Cards for the Pfizer/BioNTech vaccine, 16,345 for the Oxford University/AstraZeneca vaccine
and 39 where the brand was not specified. A higher number of doses of the Oxford University/AstraZeneca vaccine were administered in the last week than the Pfizer/BioNTech vaccine.”

These weekly data updates of the UK government + analysis are archived below. On request can email you the pdf files of Yellow Card analysis prints of a requested data lock date for data mining.

“In the week since the previous summary for 21 March 2021 we have received a further 2,608 Yllow Cards for the Pfizer/BioNTech vaccine, 16,345 for the Oxford University/AstraZeneca vaccine
and 39 where the brand was not specified. A higher number of doses of the Oxford University/AstraZeneca vaccine were administered in the last week than the Pfizer/BioNTech vaccine.”

By 11 March, about 300 000 adverse “reactions” and 508 fatalities were listed in the UK Yellow Card reports after the covid vaccines.

UPDATE 7 March 2021

The UK government reports:
For both vaccines the overall reporting rate is around
3 to 6 Yellow Cards per 1,000 doses administered.

Pfizer: 237 (+10) dead 100,809 reactions
AstraZeneca: 289 (+14) dead 228,337 reactions
unspecified: 8 (+2) dead 917 reactions
Total 554 (+46) dead by 7 March 2021
Total reactions: 330,063
 [by 7 March (1-7 March week)]

The numbers above also show that AstraZeneca side effects are a multitude more frequent than those of the Pfizer vaccine.
An estimated 10.9 million first doses of the Pfizer/BioNTech vaccine and 11.7 million doses of the Oxford University/AstraZeneca vaccine, and around one million second doses, mostly the Pfizer/BioNTech vaccine had been administered by 7 March 2021.

Weekly update Covid Vaccine Yellow Card Sources:
AstraZeneca analysis print (52page pdf)
mRNA Pfizer– BioNTech analysis print (54 page pdf)
COVID-19 brand unspecified analysis print (23 pages)

Graphic: 1st dose daily administered in the UK by 3 March
Graphic: 1st dose daily administered in the UK by 3 March
First dose total: 20,703,615. Second dose total: 895,412 []
It looks like the uptake of the 1st shot is slowing down.

UPDATE 28 February 2021

The UK government reports33,207 Yellow Cards have been reported for the Pfizer/BioNTech54,180 have been reported for the Oxford University/AstraZeneca vaccine, and 251 have been reported where the brand of the vaccine was not specified.
For both vaccines the overall reporting rate is around
3 to 6 Yellow Cards per 1,000 doses administered.

Total Pfizer deaths227(+15) – AstraZeneca: 275 (+31)
(+1.3 mio Pf vaccinated) – (+1.3 mio AZ vaccinated)
unspecified brand: 6 (+0)
Total reported deaths: 508 (+48) in week 21-28 Feb 2021
Twice as many deaths with AstraZeneca this week.

The above deaths are just the tip of the iceberg:
less than 1% of adverse reactions are reported.
At least 20,275,451 people have received their first vaccination in the UK by week ending 28 February 2021, with 815,816 second doses administered.
An analysis of the most common vaccine side effects, reveals:

The report rate in the UK population is less than 1%:

Comparing side effects of Pfizer and AstraZeneca covid vaccine trials with UK Yellow Card reports of adverse reactions 28 February 2021
The comparison of side effects recorded in the vaccine trials with those reported in the UK YellowCard Scheme by 28 February 2021 reveal:
1) AstraZeneca shows most side effects – many more than the Pfizer vaccine
2) Far less than 1% of post vaccine side effects are reported in the Yellow Card scheme

The numbers above also show that AstraZeneca side effects are a multitude more frequent than those of the Pfizer vaccine.

An estimated 10.7 million first doses of the Pfizer/BioNTech vaccine and 9.7 million doses of the Oxford University/AstraZeneca vaccine, had been administered, and around 0.8 million second doses, mostly the Pfizer/BioNTech vaccine, had been administered.
Pfizer/BioNTech vaccine reports include a total of 94,809 reactions
AstraZeneca vaccine reports include a total of 201,622 reactions

“In the week since the previous summary for 21 February 2021 the MHRA have received a further 3,482 Yellow Cards for the Pfizer/BioNTech vaccine and 11,263 for the Oxford University/AstraZeneca vaccine” = 3x more for AstraZeneca.
30-40% of healthy trial volunteers reported “myalgia” – that should be 3-4 million of the UK population.
More than twice as many AstraZeneca adverse total reactions
All above data are from the UK government analysis prints for
Oxford/AstraZeneca & mRNA PfizerBioNTech and MHRA

Update UK data 21 February

4 March: the UK government published the latest cumulative total numbers of reactions and fatalities HERE.

Update 3rd Feb week 14-21 Feb Covid-19 vaccines:
Pfizer: 15 deaths + 7,972 reactions
, 1.1mio vaccinated
AstraZ: 39 deaths + 43,012 reactions, 1.5mio vaccinated
Unspecified vaccine: 0 deaths + 191 reactions
= 54 deaths + 51,175 reactions in one week.
– – – – –
Cumulative TOTAL: 460 UK deaths 
243,612 reactions by 21 Feb 2021
(Pfizer: 212 deaths + 85,179 reactions.
AstraZeneca244 deaths + 157,637 reactions.
Unspecified vaccine: 4 deaths + 796 reactions
[source: UK data Drug Analysis Print Yellow Card]

The REAL numbers are probably more than 20x higher as explained above.
The media report deaths after the covid-19 jab usually as “coincidental” – or they attribute deaths to a “covid outbreak” (positive PCR test result).
The above week (14-21 February) data is the difference between totals between the 14 Feb (see below) and 21 Feb cumulative totals.

As of 21 February, an estimated
9.4 million first doses of the Pfizer/BioNTech vaccine and
8.4 million doses of the Oxford University/AstraZeneca vaccine, had been administered, and around 0.6 million second doses, mostly the Pfizer/BioNTech vaccine, had been administered [source: UK gov]

Data Analysis Deaths in the week 14-21 February 2021:
Pfizer: 1.1mio / 15 deaths = 1 death / 73,333 vaccinated
AstraZ: 1.5mio/39 deaths = 1 death / 38,461.5 vaccinated
[deaths related to the vaccines given in the same week]
You are nearly twice as likely to die after the AstraZeneca vaccine than after the shot from Pfizer.

UK data up to 14 February 2021

Update 2nd week 8-14 Feb Covid-19 vaccines:
AstraZeneca: 55 deaths
 + 40 742 reactions.
Pfizer: 24 deaths + 6 893 reactions.
Unspecified vaccine: 4 deaths + 605 reactions
= 83 deaths in the 2nd February week.

Cumulative total = 406 UK deaths by 14 Feb
[UK data Drug Analysis Yellow Card]

17,582,121 people have received their first vaccination in UK by week ending 14 February 2021, with 615,148 second doses administered
[UK Public Health].

“As of 14 February, an estimated total of 15.2 Mio doses
(8.3 million first doses of the Pfizer/BioNTech vaccine
and 6.9 million doses of the Oxford University/AstraZeneca vaccine), had been administered, and around 0.6 million second doses, mostly the Pfizer/BioNTech vaccine, had been administered”
Coronavirus vaccine – weekly summary of Yellow Card reporting

Analysis 2 weeks 1-14 February 2021
Pfizer: 1.7mio/54 deaths = 1 death / 31,481 vaccinated
AstraZ: 3.9mio/115 deaths = 1 death/33,913 vaccinated
[deaths related to the vaccines given in the same 2 weeks]

UK Data 1st February Week 2021

UPDATE in the first February week: alone, there were
30 deaths + 10 700 “reactions” recorded after the Pfizer vaccine
60 deaths and 31 234 “reactions” after the AstraZeneca shot.
That is 90 deaths in ONE week (1-7 Feb 2021).
Total UK deaths: 173 + 150 = 323 Pfizer AstraZeneca combined
Totsl UK ‘reactions’: 70 314+73 883=144 197 for both vaccines.
Consider: less than 10% of vaccine related incidents are reported.

Update from the 1-7 February 2021 UK Drug Analysis Print with increased totals
showing Pfizer: 173 deaths (+30) and 70 314 “Reactions” (+10 700 in one week)
AstraZeneca: 150 deaths (+ 60) and 73 883 “Reactions” (+31 234 in one week)
Please note: the Yellow card deaths and reactions only show totals since the count began. By subtracting the totals from 31 January, we get the numbers for one week.

UK Data 31 January 2021

As of 31 January, an estimated 6.6 million first doses of the Pfizer/BioNTech mRNA vaccine and 3 million doses of the Oxford University/AstraZeneca viral vector vaccine had been administered in the UK, and around 0.5 million second doses, mostly the Pfizer/BioNTech vaccine.
From the UK government weekly summary of Yellow Card reporting, 9 Dec 2020 to 31 January 2021:
As of 31 January 2021, for the UK:
• “20,319 Yellow Cards have been reported for the Pfizer / BioNTech
• 11,748 have been reported for the Oxford University / AstraZeneca vaccine
• 72 have been reported where the brand of the vaccine was not specified

Events with fatal outcome:
“The MHRA has received 143 UK reports of suspected ADRs to the Pfizer/BioNTech vaccine in which the patient died shortly after vaccination90 reports for the Oxford University/AstraZeneca vaccine.”
“The MHRA has received 130 UK spontaneous adverse reactions associated with anaphylaxis or anaphylactoid reactions with the Pfizer/BioNTech vaccination…
and 30 reports of anaphylaxis have been received for the COVID-19 Oxford University/AstraZeneca vaccine.”
Bell’s Palsy:
99 reports of facial paralysis or paresis with Pfizer/BioNTech vaccine… and 15 reports of facial paralysis have been received for the COVID-19 Oxford University/AstraZeneca vaccine.”

Weekly update Covid Vaccine Yellow Card Sources:
AstraZeneca analysis print (52page pdf)
mRNA Pfizer– BioNTech analysis print (54 page pdf)
COVID-19 brand unspecified analysis print (23 pages)

That is 40x more deaths than expected after a flu vaccine!
WHO statement from 2013:
for every 10 million individuals vaccinated [against Influenza A (H1N1)] in the UK, 21.5 cases of Guillain-Barré syndrome and 5.75 sudden deaths were expected to occur as unrelated coincidental events within 6 weeks of vaccination. 34” [VACCINE SAFETY BASICS, p 77]

comparison Pfizer and AstraZeneca vaccine cumulative total reactions and deaths by 31 January 2021
mRNA Pfizer– BioNTech analysis print Totals 9 Dec 2020 – 31 Jan 2021 (1st 52 days)
AstraZeneca analysis print Totals (4 – 31 Jan 2021 (1st 27 days)
The above screenshot shows data until 31 January (submitted by 10 Feb)

The following calculation is for 31 January 2021:
Analysis Pfizer: 6.6 million first vaccines administered
6,600 000 / 143 deaths = one death per 46,153 people
59 614 reactions / 143 deaths = one death each 416.88 reactions
143 deaths / 52 days = one vaccine death every 2.75 days
Analysis AstraZeneca: 3 million first vaccines administered
3,000 000 / 90 deaths = one death per 33,333 people
42 649 reactions / 90 deaths = one death each 473.88 reactions
90 deaths / 27 days = one vaccine death every 3.33 days

In the last decades, less than 10% of vaccine reactions and fatalities have been reported with the Yellow Card scheme – nearly always they are considered “coincidental”, but not causal [BMJ].
A study found, that in the US “Vaccine Adverse Event Reporting System” VAERS “fewer than 1% of vaccine adverse events are reported
So the real vaccine adverse effects and deaths will be likely to be more than 20 times higher.
Vaccine authorities don’t really want to know about adverse effects.
QUESTION: are UK vaccine deaths after day 8 included?

Data compiled from

Up to TOP Table of Content  *  Contact

Recommended reading on

We Need To Focus On The Immune System

Did We Get It All Wrong Fighting The Virus?

PCR Test: Use or Abuse?

Face Masks and Covid-19

Home / About * Contact